フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Medivir to present at the Redeye Fight Cancer Day PR Newswire STOCKHOLM, Jan. 16, 2023 STOCKHOLM, Jan. 16, 2023 /PRNewswire/ -- Medivir AB...
Medivir partner Infex Therapeutics receives FDA QIDP designation PR Newswire STOCKHOLM, Jan. 11, 2023 STOCKHOLM, Jan. 11, 2023 /PRNewswire/...
Medivir has completed a successful pre-IND meeting with the FDA PR Newswire STOCKHOLM, Dec. 12, 2022 STOCKHOLM, Dec. 12, 2022 /PRNewswire/...
Medivir to present at the Erik Penser Bank Healthcare Day PR Newswire STOCKHOLM, Nov. 29, 2022 STOCKHOLM, Nov. 29, 2022 /PRNewswire/ -- Medivir...
Medivir recruits Pia Baumann as new Chief Medical Officer PR Newswire STOCKHOLM, Nov. 21, 2022 STOCKHOLM, Nov. 21, 2022 /PRNewswire/ -- Medivir...
Medivir to present at the Redeye Life Science Day PR Newswire STOCKHOLM, Nov. 16, 2022 STOCKHOLM, Nov. 16, 2022 /PRNewswire/ -- Medivir AB...
Medivir presents new data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC Immunotherapy...
MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2022 PR Newswire STOCKHOLM, Nov. 3, 2022 STOCKHOLM, Nov. 3, 2022 /PRNewswire/ -- The measures to...
Nomination Committee of Medivir appointed PR Newswire STOCKHOLM, Oct. 28, 2022 STOCKHOLM, Oct. 28, 2022 /PRNewswire/ -- Medivir AB (Nasdaq: MVIR...
Medivir to present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire STOCKHOLM, Sept. 12, 2022 STOCKHOLM, Sept. 12...
Medivir to present data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC 2022 Annual...
Medivir to present at the Pareto Securities´ Healthcare conference PR Newswire STOCKHOLM, Sept. 1, 2022 STOCKHOLM, Sept. 1, 2022 /PRNewswire/...
Medivir to present at the Erik Penser Bank Company Day PR Newswire STOCKHOLM, Aug. 23, 2022 STOCKHOLM, Aug. 23, 2022 /PRNewswire/ -- Medivir AB...
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire STOCKHOLM, Aug. 19, 2022 STOCKHOLM, Aug. 19, 2022 /PRNewswire/ -- The clinical...
Medivir to present at the ABGSC Life Science Summit PR Newswire HUDDINGE, Sweden, May 17, 2022 HUDDINGE, Sweden, May 17, 2022 /PRNewswire/...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約